Published in Healthcare Finance, Tax and Law Weekly, September 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Inverness Medical Innovations, Inc.
Report 1: Inverness Medical Innovations, Inc. (AMEX:IMA) and HemoSense, Inc. (AMEX:HEM) announced that they have entered into a definitive agreement for Inverness to acquire Hemosense in an all stock deal. Each holder of a share of HemoSense common stock will receive 0.274192 shares of Inverness common stock in the transaction, which represents a 37.5% premium, based on the average trading prices of both companies over the last 5 trading...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly